The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Insulet Corporation (NASDAQ: PODD) has announced its plan to offer $450 million aggregate principal amount of senior ...

Insulet (Nasdaq:PODD) announced today that SVP and Chief Technology Officer Mark Field is departing the company.

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new geographies.

AID system powered by Tidepool expected to launch Q2 2025 in the U.S. with Abbott’s FreeStyle Libre® 3 Plus sensorMANCHESTER, N.H., March 18, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company ...

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its revolutionary Omnipod 5 Automated Insulin ...

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

There is a growing need for additional treatment options for individuals with type 2 diabetes who are being treated with ...